Long-term, non-invasive viability monitoring of paclitaxel treated cells

20 May 2021

Cell viability is generally determined via cell counting, live/dead staining, or metabolic activity assays. However, the common drawback of these methods is that they are generally invasive and can thus not be used for long-term viability monitoring.

In this application note, CytoSMART demonstrates a non-invasive alternative for these methods using confluency measurements obtained with the CytoSMART® Omni, enabling the long-term monitoring of cell viability in real-time.

Tags